aDAPt-ANOCA: Dapagliflozin for the Treatment of Angina With Non-Obstructive Coronary Artery Disease (ANOCA)

Clinical trial NCT07741890 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07741890
Sponsor: The Christ Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Angina With Non-Obstructive Coronary Artery Disease Coronary Microvascular Dysfunction (CMD)

Start date: 2026-09-01
Primary completion: 2028-12-01
Enrollment: 120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.